Ronald Boellaard
#116,573
Most Influential Person Now
Researcher
Ronald Boellaard's AcademicInfluence.com Rankings
Download Badge
Physics Biology
Ronald Boellaard's Degrees
- PhD Medical Physics University of Amsterdam
- Masters Physics University of Amsterdam
- Bachelors Physics University of Amsterdam
Why Is Ronald Boellaard Influential?
(Suggest an Edit or Addition)Ronald Boellaard's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 (2014) (1949)
- FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 (2009) (1255)
- The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. (2020) (974)
- Standards for PET Image Acquisition and Quantitative Data Analysis (2009) (776)
- Imaging biomarker roadmap for cancer studies (2016) (718)
- Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. (2004) (659)
- Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography Study (2008) (527)
- 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer (2018) (380)
- 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies. (2003) (362)
- Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability (2013) (346)
- The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis (2015) (337)
- Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner (2007) (332)
- Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters (2007) (295)
- Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer (2018) (280)
- FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC (2018) (278)
- Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0 (2018) (271)
- The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials (2008) (267)
- Performance Characteristics of the Digital Biograph Vision PET/CT System (2019) (252)
- Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial (2005) (220)
- Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum (2009) (218)
- Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [18F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation (2016) (214)
- Experimental and clinical evaluation of iterative reconstruction (OSEM) in dynamic PET: quantitative characteristics and effects on kinetic modeling. (2001) (208)
- Performance of Immuno–Positron Emission Tomography with Zirconium-89-Labeled Chimeric Monoclonal Antibody U36 in the Detection of Lymph Node Metastases in Head and Neck Cancer Patients (2006) (202)
- EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies (2017) (197)
- Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum (2008) (190)
- Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies (2011) (188)
- Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer. (2005) (185)
- The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials (2008) (181)
- Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PET (2001) (174)
- Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography. (2011) (171)
- Relationship of Cerebrospinal Fluid Markers to 11C-PiB and 18F-FDDNP Binding (2009) (168)
- Repeatability of 18F-FDG Uptake Measurements in Tumors: A Metaanalysis (2012) (166)
- Quantifying heterogeneity in human tumours using MRI and PET. (2012) (165)
- Radiation Dosimetry of 89Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients (2009) (159)
- Partial volume correction strategies for quantitative FDG PET in oncology (2009) (152)
- Repeatability of 18F-FDG PET in a Multicenter Phase I Study of Patients with Advanced Gastrointestinal Malignancies (2009) (146)
- Microglial activation in healthy aging (2012) (143)
- Microglial activation in Alzheimer's disease: an (R)-[11C]PK11195 positron emission tomography study (2013) (142)
- Need for Standardization of 18F-FDG PET/CT for Treatment Response Assessments (2011) (142)
- Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET (2012) (142)
- Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET (2017) (141)
- Longitudinal Amyloid Imaging Using 11C-PiB: Methodologic Considerations (2013) (141)
- Image-derived input functions for determination of MRGlu in cardiac (18)F-FDG PET scans. (2001) (140)
- Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[11C]PK11195 brain PET studies (2012) (137)
- Detection of Alzheimer Pathology In Vivo Using Both 11C-PIB and 18F-FDDNP PET (2009) (134)
- Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET. (2003) (133)
- Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder (2013) (129)
- Accuracy and precision of pseudo-continuous arterial spin labeling perfusion during baseline and hypercapnia: A head-to-head comparison with 15O H2O positron emission tomography (2014) (126)
- Evaluation of Basis Function and Linear Least Squares Methods for Generating Parametric Blood Flow Images Using 15O-Water and Positron Emission Tomography (2005) (120)
- P-Glycoprotein Function at the Blood–Brain Barrier: Effects of Age and Gender (2012) (115)
- Evaluation of Tracer Kinetic Models for Quantification of P-Glycoprotein Function using (R)-[11C]Verapamil and PET (2007) (113)
- Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement. (2012) (112)
- Repeatability of Metabolically Active Volume Measurements with 18F-FDG and 18F-FLT PET in Non–Small Cell Lung Cancer (2010) (109)
- Fluorodeoxyglucose Positron Emission Tomography for Evaluating Early Response During Neoadjuvant Chemoradiotherapy in Patients With Potentially Curable Esophageal Cancer (2011) (107)
- Noninvasive imaging of macrophages in rheumatoid synovitis using 11C-(R)-PK11195 and positron emission tomography. (2008) (105)
- Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. (2008) (105)
- Amygdala activity in obsessive-compulsive disorder with contamination fear: a study with oxygen-15 water positron emission tomography (2004) (105)
- Impact of [18F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology (2011) (104)
- (R)- and (S)-[11C]verapamil as PET-tracers for measuring P-glycoprotein function: in vitro and in vivo evaluation. (2003) (104)
- New method to obtain the midplane dose using portal in vivo dosimetry. (1998) (103)
- Transmission dosimetry with a liquid-filled electronic portal imaging device. (1996) (100)
- Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia (2013) (98)
- Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice. (2003) (97)
- 89Zr-cetuximab PET imaging in patients with advanced colorectal cancer (2015) (96)
- Optimization algorithms and weighting factors for analysis of dynamic PET studies (2006) (96)
- Simplified parametric methods for [11C]PIB studies (2008) (96)
- Evaluation of Reference Tissue Models for the Analysis of [11C](R)-PK11195 Studies (2006) (95)
- Feasibility of state of the art PET/CT systems performance harmonisation (2018) (94)
- Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients (2015) (93)
- EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0 (2020) (93)
- Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials (2015) (92)
- Arterial Spin Labeling Perfusion MRI at Multiple Delay Times: A Correlative Study with H215O Positron Emission Tomography in Patients with Symptomatic Carotid Artery Occlusion (2010) (92)
- 18F-FDG PET as a Tool to Predict the Clinical Outcome of Infliximab Treatment of Rheumatoid Arthritis: An Explorative Study (2011) (91)
- EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems (2017) (91)
- Optimized dose regimen for whole-body FDG-PET imaging (2013) (90)
- Accurate PET/MR Quantification Using Time of Flight MLAA Image Reconstruction (2014) (88)
- Development of a Tracer Kinetic Plasma Input Model for (R)-[11C]PK11195 Brain Studies (2005) (88)
- Quantitative imaging test approval and biomarker qualification: interrelated but distinct activities. (2011) (88)
- Repeatability of metabolically active tumor volume measurements with FDG PET/CT in advanced gastrointestinal malignancies: a multicenter study. (2014) (87)
- A convolution model to convert transmission dose images to exit dose distributions. (1997) (86)
- Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures (2013) (85)
- Reproducibility of quantitative 18F-3′-deoxy-3′-fluorothymidine measurements using positron emission tomography (2009) (82)
- First clinical tests using a liquid-filled electronic portal imaging device and a convolution model for the verification of the midplane dose. (1998) (80)
- Cerebral perfusion and glucose metabolism in Alzheimer’s disease and frontotemporal dementia: two sides of the same coin? (2015) (79)
- Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results (2010) (78)
- Partial volume corrected image derived input functions for dynamic PET brain studies: Methodology and validation for [11C]flumazenil (2008) (76)
- HRRT Versus HR+ Human Brain PET Studies: An Interscanner Test–Retest Study (2009) (75)
- Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial (2005) (74)
- Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapy. (2012) (73)
- Two-dimensional exit dosimetry using a liquid-filled electronic portal imaging device and a convolution model. (1997) (72)
- Mutatis Mutandis: Harmonize the Standard! (2012) (71)
- Widespread and Prolonged Increase in (R)-11C-PK11195 Binding After Traumatic Brain Injury (2011) (71)
- The dose response relationship of a liquid-filled electronic portal imaging device. (1996) (70)
- In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients (2013) (70)
- Perfusable tissue index as a potential marker of fibrosis in patients with idiopathic dilated cardiomyopathy. (2004) (70)
- Repeatability of 18F‐FDG PET radiomic features: A phantom study to explore sensitivity to image reconstruction settings, noise, and delineation method (2018) (69)
- Increased cerebral (R)-[11C]PK11195 uptake and glutamate release in a rat model of traumatic brain injury: a longitudinal pilot study (2011) (69)
- Comparison of Plasma Input and Reference Tissue Models for Analysing [11C]flumazenil Studies (2008) (68)
- Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology (2012) (68)
- Effects of Image Characteristics on Performance of Tumor Delineation Methods: A Test–Retest Assessment (2011) (68)
- Evaluation of Reference Regions for (R)-[11C]PK11195 Studies in Alzheimer's Disease and Mild Cognitive Impairment (2007) (67)
- Quantitative Analysis of Response to Treatment with Erlotinib in Advanced Non–Small Cell Lung Cancer Using 18F-FDG and 3′-Deoxy-3′-18F-Fluorothymidine PET (2011) (67)
- Impact of anatomical and functional severity of coronary atherosclerotic plaques on the transmural perfusion gradient: a [15O]H2O PET study. (2013) (67)
- Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysis (2011) (66)
- In vivo (R)-[11C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis (2016) (65)
- Multicenter Harmonization of 89Zr PET/CT Performance (2014) (65)
- Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non–Small Cell Lung Cancer Patients (2016) (64)
- High-quality 124I-labelled monoclonal antibodies for use as PET scouting agents prior to 131I-radioimmunotherapy (2004) (63)
- Test-retest variability of quantitative [11C]PIB studies in Alzheimer’s disease (2009) (62)
- 18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome (2008) (61)
- Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17–21, 2014, Tübingen, Germany (2015) (61)
- Day-to-Day Test–Retest Variability of CBF, CMRO2, and OEF Measurements Using Dynamic 15O PET Studies (2010) (60)
- Reproducibility of quantitative (R)-[11C]verapamil studies (2012) (60)
- Quantitative oncology molecular analysis suite: ACCURATE (2018) (58)
- Does myocardial fibrosis hinder contractile function and perfusion in idiopathic dilated cardiomyopathy? PET and MR imaging study. (2006) (57)
- Bone formation rather than inflammation reflects Ankylosing Spondylitis activity on PET-CT: a pilot study (2012) (57)
- Investigating the state-of-the-art in whole-body MR-based attenuation correction: an intra-individual, inter-system, inventory study on three clinical PET/MR systems (2016) (56)
- Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial. (2019) (56)
- Current image acquisition options in PET/MR. (2015) (56)
- Image-derived input functions for PET brain studies (2009) (55)
- Quality control for quantitative multicenter whole-body PET/MR studies: A NEMA image quality phantom study with three current PET/MR systems. (2015) (54)
- Quantitative comparison of analytic and iterative reconstruction methods in 2- and 3-dimensional dynamic cardiac 18F-FDG PET. (2004) (54)
- Reproducibility of Tumor Perfusion Measurements Using 15O-Labeled Water and PET (2008) (53)
- 89Zr-immuno-PET for imaging of long circulating drugs and disease targets: why, how and when to be applied? (2015) (52)
- Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET (2006) (52)
- Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions (2014) (51)
- Comparison of 3D-OP-OSEM and 3D-FBP reconstruction algorithms for High-Resolution Research Tomograph studies: effects of randoms estimation methods (2008) (50)
- Validated imaging biomarkers as decision-making tools in clinical trials and routine practice: current status and recommendations from the EIBALL* subcommittee of the European Society of Radiology (ESR) (2019) (50)
- Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer. (2008) (50)
- Neurophysiological Effects of Sleep Deprivation in Healthy Adults, a Pilot Study (2015) (50)
- RaCaT: An open source and easy to use radiomics calculator tool (2019) (50)
- Correction methods for missing data in sinograms of the HRRT PET scanner (2002) (49)
- Accuracy of 3-Dimensional Reconstruction Algorithms for the High-Resolution Research Tomograph (2008) (48)
- Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis (2015) (48)
- Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies (2017) (47)
- Image-Derived Input Function for Human Brain Using High Resolution PET Imaging with [11C](R)-rolipram and [11C]PBR28 (2011) (47)
- 18F-FDG PET image biomarkers improve prediction of late radiation-induced xerostomia. (2017) (46)
- Experimental Multicenter and Multivendor Evaluation of the Performance of PET Radiomic Features Using 3-Dimensionally Printed Phantom Inserts (2020) (46)
- Combined PET/MRI: Global Warming—Summary Report of the 6th International Workshop on PET/MRI, March 27–29, 2017, Tübingen, Germany (2017) (46)
- Characterization of a single LSO crystal layer high resolution research tomograph. (2003) (46)
- Tumor Lesion Glycolysis and Tumor Lesion Proliferation for Response Prediction and Prognostic Differentiation in Patients With Advanced Non–Small Cell Lung Cancer Treated With Erlotinib (2012) (46)
- PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer. (2017) (45)
- Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib (2012) (45)
- Combined PET/MR: Where Are We Now? Summary Report of the Second International Workshop on PET/MR Imaging April 8–12, 2013, Tubingen, Germany (2014) (45)
- Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET. (2005) (45)
- Integration of FDG- PET/CT into external beam radiation therapy planning (2012) (45)
- Image Quality and Semiquantitative Measurements on the Biograph Vision PET/CT System: Initial Experiences and Comparison with the Biograph mCT (2020) (44)
- Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer (2020) (44)
- Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment (2009) (43)
- Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study (2019) (43)
- Summary Report of the First International Workshop on PET/MR Imaging, March 19–23, 2012, Tübingen, Germany (2013) (42)
- Pilot study of 89Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancer (2014) (42)
- Image derived input functions for dynamic High Resolution Research Tomograph PET brain studies (2008) (41)
- PET/CT-Derived Whole-Body and Bone Marrow Dosimetry of 89Zr-Cetuximab (2015) (41)
- Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial - (2020) (41)
- Comparative Study With New Accuracy Metrics for Target Volume Contouring in PET Image Guided Radiation Therapy (2013) (41)
- Radiomics analysis of pre-treatment [18F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment (2018) (40)
- Dual-Phase PET-CT to Differentiate [18F]Fluoromethylcholine Uptake in Reactive and Malignant Lymph Nodes in Patients with Prostate Cancer (2012) (40)
- Quantification of Tau Load Using [18F]AV1451 PET (2017) (40)
- Amyloid and its association with default network integrity in Alzheimer's disease (2014) (40)
- Multitracer model for staging cortical amyloid deposition using PET imaging (2020) (39)
- EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3 (2021) (39)
- Evaluation of Methods for Generating Parametric (R)-[11C]PK11195 Binding Images (2007) (39)
- Cerebral microglia activation in hepatitis C virus infection correlates to cognitive dysfunction (2016) (39)
- Prognostic Impact of [18F]Fluorothymidine and [18F]Fluoro-D-Glucose Baseline Uptakes in Patients with Lung Cancer Treated First-Line with Erlotinib (2013) (38)
- Comparative biodistribution analysis across four different 89Zr-monoclonal antibody tracers—The first step towards an imaging warehouse (2018) (38)
- Hyperaemic microvascular resistance is not increased in viable myocardium after chronic myocardial infarction. (2007) (37)
- In vivo Validation of Reconstruction-Based Resolution Recovery for Human Brain Studies (2010) (37)
- Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers (2021) (37)
- Bias Reduction for Low-Statistics PET: Maximum Likelihood Reconstruction With a Modified Poisson Distribution (2015) (37)
- Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis (2017) (37)
- Guidelines for the content and format of PET brain data in publications and archives: A consensus paper (2020) (37)
- Matching PET and CT scans of the head and neck area: development of method and validation. (2002) (37)
- Microvascular Function in Viable Myocardium After Chronic Infarction Does Not Influence Fractional Flow Reserve Measurements (2007) (37)
- Quantitative implications of the updated EARL 2019 PET–CT performance standards (2019) (36)
- Off-line motion correction methods for multi-frame PET data (2009) (36)
- The QIBA Profile for FDG PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy. (2020) (36)
- PPET: A software tool for kinetic and parametric analyses of dynamic PET studies (2006) (36)
- A Guide to ComBat Harmonization of Imaging Biomarkers in Multicenter Studies (2021) (36)
- Quantification of PD-L1 Expression with 18F-BMS-986192 PET/CT in Patients with Advanced-Stage Non–Small Cell Lung Cancer (2020) (36)
- Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium (2020) (35)
- Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-Analysis (2017) (35)
- Kinetic analysis in human brain of [11C](R)-rolipram, a positron emission tomographic radioligand to image phosphodiesterase 4: A retest study and use of an image-derived input function (2011) (35)
- Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review. (2019) (34)
- Technical and instrumentational foundations of PET/MRI. (2017) (34)
- Quantification of (R)-[11C]PK11195 binding in rheumatoid arthritis (2009) (34)
- Measurement of 18F-FDG concentrations in blood samples: comparison of direct calibration and standard solution methods. (2003) (34)
- Quantification of subendocardial and subepicardial blood flow using 15O-labeled water and PET: experimental validation. (2006) (33)
- Experimental evaluation of iterative reconstruction versus filtered back projection for 3D [15O]water PET activation studies using statistical parametric mapping analysis (2003) (33)
- Image Quality and Activity Optimization in Oncologic 18F-FDG PET Using the Digital Biograph Vision PET/CT System (2020) (33)
- Evaluation of Tracer Kinetic Models for Analysis of [18F]FDDNP Studies (2009) (32)
- SPM analysis of parametric (R)-[11C]PK11195 binding images: Plasma input versus reference tissue parametric methods (2007) (32)
- Discordant amyloid-β PET and CSF biomarkers and its clinical consequences (2019) (32)
- Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures (2020) (30)
- Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients (2013) (30)
- Gap Filling Strategies for 3-D-FBP Reconstructions of High-Resolution Research Tomograph Scans (2008) (30)
- Downregulation of 18F-FDG Uptake in PET as an Early Pharmacodynamic Effect in Treatment of Non–Small Cell Lung Cancer with the mTOR Inhibitor Everolimus (2009) (29)
- Impact of attenuation correction strategies on the quantification of High Resolution Research Tomograph PET studies (2008) (29)
- Simplified Methods for Quantification of 18F-DCFPyL Uptake in Patients with Prostate Cancer (2019) (29)
- Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy. (2019) (29)
- Study of 89Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer (2021) (29)
- Does PET Reconstruction Method Affect Deauville Scoring in Lymphoma Patients? (2018) (29)
- Measurement of metabolic tumor volume: static versus dynamic FDG scans (2011) (29)
- Accuracy and Precision of Partial-Volume Correction in Oncological PET/CT Studies (2016) (29)
- Reference Tissue Models and Blood–Brain Barrier Disruption: Lessons from (R)-[11C]PK11195 in Traumatic Brain Injury (2009) (29)
- Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer’s disease PET studies (2018) (29)
- Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours – a clinical physics perspective (2016) (28)
- Radiomics in Vulvar Cancer: First Clinical Experience Using 18F-FDG PET/CT Images (2018) (28)
- 18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma (2021) (28)
- Impact of PET/CT system, reconstruction protocol, data analysis method, and repositioning on PET/CT precision: An experimental evaluation using an oncology and brain phantom (2017) (28)
- Standardization of Quantitative Imaging: The Time Is Right, and 18F-FDG PET/CT Is a Good Place to Start (2011) (27)
- Quantification of [18F]florbetapir: A test–retest tracer kinetic modelling study (2018) (27)
- Attenuation correction of PET activation studies in the presenceof task-related motion (2003) (27)
- Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum (2019) (26)
- PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non–Small Cell Lung Cancer (2021) (26)
- Advanced analytics and artificial intelligence in gastrointestinal cancer: a systematic review of radiomics predicting response to treatment (2020) (26)
- Comparison of Velocity- and Acceleration-Selective Arterial Spin Labeling with [15O]H2O Positron Emission Tomography (2015) (26)
- Test-Retest Variability of Various Quantitative Measures to Characterize Tracer Uptake and/or Tracer Uptake Heterogeneity in Metastasized Liver for Patients with Colorectal Carcinoma (2014) (26)
- Parametric Binding Images of the TSPO Ligand 18F-DPA-714 (2016) (26)
- 89Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo (2019) (25)
- Quantitative and Simplified Analysis of 11C-Erlotinib Studies (2016) (25)
- In vivo tau pathology is associated with synaptic loss and altered synaptic function (2021) (25)
- Comparison of Simplified Parametric Methods for Visual Interpretation of 11C-Pittsburgh Compound-B PET Images (2014) (25)
- Multiparametric functional MRI and 18F-FDG-PET for survival prediction in patients with head and neck squamous cell carcinoma treated with (chemo)radiation (2020) (25)
- Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients (2019) (25)
- The perfusable tissue index: A marker of myocardial viability (2003) (25)
- Textural features of 18F-fluorodeoxyglucose positron emission tomography scanning in diagnosing aortic prosthetic graft infection (2016) (24)
- Optimizing Workflows for Fast and Reliable Metabolic Tumor Volume Measurements in Diffuse Large B Cell Lymphoma (2020) (24)
- Preclinical evaluation of [(18)F]PK-209, a new PET ligand for imaging the ion-channel site of NMDA receptors. (2015) (23)
- Pemetrexed Induced Thymidylate Synthase Inhibition in Non-Small Cell Lung Cancer Patients: A Pilot Study with 3′-Deoxy-3′-[18F]fluorothymidine Positron Emission Tomography (2013) (23)
- Software tools for standardized analysis of FDG whole body studies in multi-center trials (2008) (23)
- Measurement of left ventricular volumes and function with O-15-labeled carbon monoxide gated positron emission tomography: Comparison with magnetic resonance imaging (2005) (23)
- Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC. (2014) (23)
- Retrospective quality control review of FDG scans in the imaging sub-study of PALETTE EORTC 62072/VEG110727: a randomized, double-blind, placebo-controlled phase III trial (2015) (23)
- PET Tracers for Imaging of ABC Transporters at the Blood-Brain Barrier: Principles and Strategies. (2016) (23)
- 18F-FDG or 3′-Deoxy-3′-18F-Fluorothymidine to Detect Transformation of Follicular Lymphoma (2015) (22)
- Prognostic value of total lesion glycolysis and metabolic active tumor volume in non-small cell lung cancer. (2017) (22)
- Quantification of Dynamic 11C-Phenytoin PET Studies (2015) (22)
- Methodological aspects of multicenter studies with quantitative PET. (2011) (22)
- Accurate Delineation of Glioma Infiltration by Advanced PET/MR Neuro-Imaging (FRONTIER Study): A Diagnostic Study Protocol. (2016) (22)
- Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer (2016) (21)
- Interaction of quantitative 18F‐FDG‐PET‐CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma (2016) (21)
- Quantification of 18F-Fluorocholine Kinetics in Patients with Prostate Cancer (2015) (21)
- Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease (2020) (21)
- Model selection criteria for dynamic brain PET studies (2017) (21)
- Nuclear Medicine and Artificial Intelligence: Best Practices for Algorithm Development (2021) (21)
- [18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches (2016) (21)
- Assessment of Simplified Methods to Measure 18F-FLT Uptake Changes in EGFR-Mutated Non–Small Cell Lung Cancer Patients Undergoing EGFR Tyrosine Kinase Inhibitor Treatment (2014) (21)
- Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index (2022) (20)
- PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases (2019) (20)
- Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients. (2021) (20)
- Challenges of quantification of TSPO in the human brain (2015) (20)
- Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial (2020) (20)
- The engagement of FDG PET/CT image quality and harmonized quantification: from competitive to complementary (2015) (20)
- Influence of ROI definition, partial volume correction and SUV normalization on SUV–survival correlation in oesophageal cancer (2010) (20)
- The Association of Glucose Metabolism and Eigenvector Centrality in Alzheimer's Disease (2016) (20)
- Postinjection transmission scanning in myocardial 18F-FDG PET studies using both filtered backprojection and iterative reconstruction. (2004) (19)
- Quantitative PET in the 2020s: a roadmap (2020) (19)
- Validation of a multiwell gamma-counter for measuring high-pressure liquid chromatography metabolite profiles. (2004) (19)
- Healthy Tissue Uptake of 68Ga-Prostate-Specific Membrane Antigen, 18F-DCFPyL, 18F-Fluoromethylcholine, and 18F-Dihydrotestosterone (2019) (19)
- Quantitative Experimental Comparison of HRRT versus HR+ PET Brain Studies (2006) (19)
- Population Pharmacokinetic Analysis for Simultaneous Determination of Bmax and KDIn Vivo by Positron Emission Tomography (2005) (19)
- Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative 18F-FDG PET/CT analysis (2018) (19)
- A novel partial volume correction method for accurate quantification of [18F] flortaucipir in the hippocampus (2018) (19)
- Variability and Repeatability of Quantitative Uptake Metrics in 18F-FDG PET/CT of Non–Small Cell Lung Cancer: Impact of Segmentation Method, Uptake Interval, and Reconstruction Protocol (2018) (18)
- Effects of rigid and non-rigid image registration on test-retest variability of quantitative [18F]FDG PET/CT studies (2012) (18)
- EARL FDG-PET/CT accreditation program: Feasibility, overview and results of first 55 successfully accredited sites (2013) (18)
- Interim positron emission tomography scan in multi-center studies: optimization of visual and quantitative assessments (2009) (18)
- NEOadjuvant therapy monitoring with PET and CT in Esophageal Cancer (NEOPEC-trial) (2008) (18)
- Partial volume correction of brain PET studies using iterative deconvolution in combination with HYPR denoising (2017) (18)
- Reproducibility of quantitative 18 F-3 ′-deoxy-3 ′-fluorothymidine measurements using positron emission tomography (2009) (18)
- Quantification of the novel N-methyl-d-aspartate receptor ligand [11C]GMOM in man (2015) (18)
- Evaluation of the depth of interaction (DOI) for the High Resolution Research Tomograph (HRRT) - a comparison between scanners with and without DOI (2002) (17)
- PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variability (2020) (17)
- Parametric Methods for Quantification of 18F-FAZA Kinetics in Non–Small Cell Lung Cancer Patients (2014) (17)
- A systematic review and quality of reporting checklist for repeatability and reproducibility of radiomic features (2021) (17)
- [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer (2019) (17)
- Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease (2020) (17)
- Predictive value of quantitative 18F-FDG-PET radiomics analysis in patients with head and neck squamous cell carcinoma (2020) (17)
- Test–retest repeatability of [18F]Flortaucipir PET in Alzheimer’s disease and cognitively normal individuals (2019) (17)
- Visceral adipose tissue volume is associated with premature atherosclerosis in early type 2 diabetes mellitus independent of traditional risk factors. (2019) (17)
- Multicenter CT phantoms public dataset for radiomics reproducibility tests (2019) (17)
- A new perspective for advanced positron emission tomography–based molecular imaging in neurodegenerative proteinopathies (2019) (17)
- Performance of a modified supervised cluster algorithm for extracting reference region input functions from (R)-[11C]PK11195 brain PET studies (2008) (17)
- In Vivo Evaluation of 11C-Preladenant for PET Imaging of Adenosine A2A Receptors in the Conscious Monkey (2017) (17)
- Guidelines for quality control of PET/CT scans in a multicenter clinical study (2017) (16)
- The Role of 89Zr-Immuno-PET in Navigating and Derisking the Development of Biopharmaceuticals (2021) (16)
- Variability in quantitative analysis of atherosclerotic plaque inflammation using 18F-FDG PET/CT (2017) (16)
- COVID-19 and the brain: impact on nuclear medicine in neurology (2020) (16)
- Image Derived Input Functions: Effects of Motion on Tracer Kinetic Analyses (2010) (16)
- Metabolic Biomarker–Based BRAFV600 Mutation Association and Prediction in Melanoma (2019) (16)
- Maximum-likelihood reconstruction based on a modified Poisson distribution to reduce bias in PET (2011) (16)
- Impact of Scar on Water-Perfusable Tissue Index in Chronic Ischemic Heart Disease (2006) (16)
- Limbic and motor circuits involved in symmetry behavior in Tourette's syndrome (2012) (16)
- The navigating and de-risking role of 89Zr-immuno-PET in the development of biopharmaceuticals. (2020) (16)
- Microglia activation in schizophrenia (2010) (16)
- Parametric [11C]flumazenil images (2012) (15)
- Feasibility of PET/CT system performance harmonisation for quantitative multicentre 89Zr studies (2018) (15)
- Incorporating HYPR de-noising within iterative PET reconstruction (HYPR-OSEM) (2016) (15)
- Diagnostic performance of regional cerebral blood flow images derived from dynamic PIB scans in Alzheimer’s disease (2018) (15)
- Optimization of attenuation correction for positron emission tomography studies of thorax and pelvis using count-based transmission scans (2004) (15)
- No Evidence for Additional Blood–Brain Barrier P-Glycoprotein Dysfunction in Alzheimer's Disease Patients with Microbleeds (2012) (15)
- Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer (2020) (15)
- First-in-human PET imaging with the PD-L1 antibody Zr-89-atezolizumab (2017) (15)
- Comparison of HRRT and HR+ Scanners for Quantitative (R)-[11C]verapamil, [11C]raclopride and [11C]flumazenil Brain Studies (2015) (14)
- Myocardial Oxygen Extraction Fraction Measured Using Bolus Inhalation of 15O-Oxygen Gas and Dynamic PET (2011) (14)
- Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial (2019) (14)
- Nuclear Medicine and Artificial Intelligence: Best Practices for Evaluation (the RELAINCE Guidelines) (2022) (14)
- Positron emission tomography to assess hypoxia and perfusion in lung cancer. (2014) (14)
- Factors affecting the harmonization of disease-related metabolic brain pattern expression quantification in [18F]FDG-PET (PETMETPAT) (2019) (14)
- Effects of attenuation correction and reconstruction method on PET activation studies (2003) (14)
- Parametric methods for [18F]flortaucipir PET (2018) (14)
- Use of population input functions for reduced scan duration whole-body Patlak 18F-FDG PET imaging (2021) (14)
- Pharmacokinetic Modeling of [18F]MC225 for Quantification of the P-Glycoprotein Function at the Blood–Brain Barrier in Non-Human Primates with PET (2020) (13)
- Early Response Prediction of Multiparametric Functional MRI and 18F-FDG-PET in Patients with Head and Neck Squamous Cell Carcinoma Treated with (Chemo)Radiation (2022) (13)
- Recovery of myocardial perfusion after percutaneous coronary intervention of chronic total occlusions is comparable to hemodynamically significant non‐occlusive lesions (2018) (13)
- Quantification of O-(2-[18F]fluoroethyl)-L-tyrosine kinetics in glioma (2018) (13)
- Arterial wall inflammation is increased in rheumatoid arthritis compared with osteoarthritis, as a marker of early atherosclerosis (2021) (13)
- UvA-DARE ( Digital Academic Repository ) FDG PET and PET / CT : EANM procedure guidelines for tumour PET imaging : version 1 (2009) (13)
- Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter study (2017) (12)
- Dynamic PET Image Reconstruction Utilizing Intrinsic Data-Driven HYPR4D De-noising Kernel. (2021) (12)
- Task Group 174 Report: Utilization of [18 F]Fluorodeoxyglucose Positron Emission Tomography ([18 F]FDG-PET) in Radiation Therapy. (2019) (12)
- Multiparametric Analysis of the Relationship Between Tumor Hypoxia and Perfusion with 18F-Fluoroazomycin Arabinoside and 15O-H2O PET (2016) (12)
- Validation of simplified dosimetry approaches in ⁸⁹Zr-PET/CT: the use of manual versus semi-automatic delineation methods to estimate organ absorbed doses. (2014) (12)
- Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images (2018) (12)
- Comparison of transcranial Doppler ultrasonography and positron emission tomography using a three-dimensional template of the middle cerebral artery (2009) (12)
- Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PET (2020) (12)
- SMART (SiMulAtion and ReconsTruction) PET: an efficient PET simulation-reconstruction tool (2018) (12)
- Clinically Valuable Quality Control for PET/MRI Systems: Consensus Recommendation From the HYBRID Consortium (2019) (12)
- Investigation of practical initial attenuation image estimates in TOF-MLAA reconstruction for PET/MR. (2016) (12)
- Prognostic Value of [18F]-Fluoromethylcholine Positron Emission Tomography/Computed Tomography Before Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer. (2018) (12)
- Repeatability of IVIM biomarkers from diffusion‐weighted MRI in head and neck: Bayesian probability versus neural network (2021) (11)
- Stable prediction with radiomics data (2019) (11)
- Quantitative agreement between [15O]H2O PET and model free QUASAR MRI‐derived cerebral blood flow and arterial blood volume (2016) (11)
- Semi-quantitative cerebral blood flow parameters derived from non-invasive [15O]H2O PET studies (2017) (11)
- Repeatability of arterial input functions and kinetic parameters in muscle obtained by dynamic contrast enhanced MR imaging of the head and neck. (2020) (11)
- Quality assessment of positron emission tomography scans: recommendations for future multicentre trials (2017) (11)
- The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer’s disease (2014) (11)
- The Impact of Semiautomatic Segmentation Methods on Metabolic Tumor Volume, Intensity, and Dissemination Radiomics in 18F-FDG PET Scans of Patients with Classical Hodgkin Lymphoma (2022) (11)
- Partial-volume correction in dynamic PET-CT: effect on tumor kinetic parameter estimation and validation of simplified metrics (2019) (11)
- Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysis (2019) (11)
- Pharmacokinetic modeling of a novel hypoxia PET tracer [18F]HX4 in patients with non-small cell lung cancer (2016) (11)
- Comparison of oxygen-15 PET and transcranial Doppler CO2-reactivity measurements in identifying haemodynamic compromise in patients with symptomatic occlusion of the internal carotid artery (2012) (11)
- A Clinical and Experimental Comparison of Time of Flight PET/MRI and PET/CT Systems (2015) (11)
- Hemodynamic changes in ipsi- and contralateral cerebral arterial territories after carotid endarterectomy using positron emission tomography. (2009) (10)
- Methodological Considerations in Quantification of 3'-Deoxy-3'-[18F]Fluorothymidine Uptake Measured with Positron Emission Tomography in Patients with Non-Small Cell Lung Cancer (2014) (10)
- Optimization of parathyroid 11C-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism (2019) (10)
- Plausibility and redundancy analysis to select FDG‐PET textural features in non‐small cell lung cancer (2020) (10)
- Crossed Cerebellar Diaschisis in Alzheimer's Disease. (2018) (10)
- Comparison Between the Performance of Quantitative Flow Ratio and Perfusion Imaging for Diagnosing Myocardial Ischemia. (2020) (10)
- Application of various iterative reconstruction for quantitative 3D dynamic brain PET studies (2004) (10)
- First in human evaluation of [18F]PK-209, a PET ligand for the ion channel binding site of NMDA receptors (2018) (10)
- 18F-FDG-PET uptake in non-infected total hip prostheses (2018) (10)
- Multicentre quantitative 68Ga PET/CT performance harmonisation (2019) (10)
- Moving the goalposts while scoring―the dilemma posed by new PET technologies (2021) (10)
- Harmonisation of PET/CT contrast recovery performance for brain studies (2021) (10)
- Lesion Detection and Interobserver Agreement with Advanced Image Reconstruction for 18F-DCFPyL PET/CT in Patients with Biochemically Recurrent Prostate Cancer (2020) (10)
- Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis (2018) (10)
- Effects of MR scanner type, scanning sequence and segmentation algorithm on MR-based partial volume corrections of [11C](R)-PK11195 studies (2006) (10)
- High resolution PET imaging characteristics of /sup 68/Ga, /sup 124/I and /sup 89/Zr compared to /sup 18/F (2005) (10)
- Spatial concordance of DNA methylation classification in diffuse glioma (2021) (10)
- Optimisation and harmonisation: two sides of the same coin? (2013) (10)
- Performance characteristics of the high resolution research tomograph comparison of three prototypes (2004) (10)
- Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate Cancer (2022) (9)
- Correction for emission contamination in transmission scans for the high resolution research tomograph (2003) (9)
- Influence of Outside Field of View Activity on the Quality of High Resolution Research Tomograph (HRRT) Brain studies (2006) (9)
- Simulated annealing in pharmacokinetic modeling of PET neuroreceptor studies: accuracy and precision compared with other optimization algorithms (2004) (9)
- Assessment of microglial activation in mild cognitive impairment using [11C](R)-PK11195 and PET (2006) (9)
- Image quality and semi-quantitative measurements of the Siemens Biograph Vision PET/CT: Initial experiences and comparison with Siemens Biograph mCT PET/CT (2019) (9)
- Pharmacokinetic modeling of [11C]flumazenil kinetics in the rat brain (2017) (9)
- Relationship between Extent of Ischaemic Burden and Changes in Absolute Myocardial Perfusion after Chronic Total Occlusion Percutaneous Coronary Intervention. (2020) (9)
- Quantitative assessment of 18F-FDG PET in patients with Hodgkin lymphoma: is it significantly affected by contrast-enhanced computed tomography attenuation correction? (2019) (9)
- Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study (2020) (9)
- Translation of New Molecular Imaging Approaches to the Clinical Setting: Bridging the Gap to Implementation (2016) (9)
- Subtle alterations in cerebrovascular reactivity in mild cognitive impairment detected by graph theoretical analysis and not by the standard approach (2017) (8)
- The Additional Value of Ultrafast DCE-MRI to DWI-MRI and 18F-FDG-PET to Detect Occult Primary Head and Neck Squamous Cell Carcinoma (2020) (8)
- Prediction of disease-free survival using relative change in FDG-uptake early during neoadjuvant chemoradiotherapy for potentially curable esophageal cancer: A prospective cohort study. (2016) (8)
- Simplified parametric methods for [18F]FDDNP studies (2010) (8)
- University of Groningen (18)F-FDG PET image biomarkers improve prediction of late radiation-induced xerostomia (2018) (8)
- Experimental Multicenter And Multivendor Evaluation Of Pet Radiomic Features Performance Using 3d Printed Phantom Inserts (2019) (8)
- CT-perfusion versus [(15)O]H2O PET in lung tumors: effects of CT-perfusion methodology. (2013) (8)
- Simulating the effect of cerebral blood flow changes on regional quantification of [18F]flutemetamol and [18F]florbetaben studies (2020) (8)
- Quantitative parametric maps of O-(2-[18F]fluoroethyl)-L-tyrosine kinetics in diffuse glioma (2019) (8)
- Microglia activation in recent onset schizophrenia: A quantitative (R)-[11C]PK11195 study (2008) (8)
- Optimization of the k2′ Parameter Estimation for the Pharmacokinetic Modeling of Dynamic PIB PET Scans Using SRTM2 (2019) (8)
- Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies (2019) (8)
- EARL compliance and imaging optimisation on the Biograph Vision Quadra PET/CT using phantom and clinical data (2022) (8)
- Adherence to pretreatment and intratreatment imaging of head and neck squamous cell carcinoma patients undergoing (chemo) radiotherapy in a research setting. (2020) (8)
- Kinetics and 28-day test–retest repeatability and reproducibility of [11C]UCB-J PET brain imaging (2020) (8)
- IEEE Nuclear Science Symposium Conference Record, 2008. NSS '08 (2009) (8)
- [18F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers (2021) (8)
- Altered GABAA receptor density and unaltered blood–brain barrier [11C]flumazenil transport in drug-resistant epilepsy patients with mesial temporal sclerosis (2015) (7)
- Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter? (2021) (7)
- O-145 Prognostic significance of the 18FDG-PET standardized uptake value for inoperable non-small cell lung cancer patients after high-dose radiotherapy (2005) (7)
- Strategies to reduce sample sizes in Alzheimer’s disease primary and secondary prevention trials using longitudinal amyloid PET imaging (2021) (7)
- Sensitivity of 18F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer (2019) (7)
- Functional stress imaging to predict abnormal coronary fractional flow reserve: the PACIFIC 2 study (2022) (7)
- Parametric Imaging of [11C]Flumazenil Binding in the Rat Brain (2017) (7)
- Classification of negative and positive 18F-florbetapir brain PET studies in subjective cognitive decline patients using a convolutional neural network (2020) (7)
- Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography (2021) (7)
- Tumour necrosis as assessed with 18F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements (2019) (7)
- Venous versus arterial blood samples for plasma input pharmacokinetic analysis of different radiotracer PET studies (2011) (7)
- Reference tissue kinetics extraction from [11C]-(R)-PK11195 scans on the high resolution research tomograph (HRRT) (2008) (7)
- OP 50 Initial experience with the EANM accreditation procedure of FDG PET/CT devices (2011) (7)
- In vivo dosimetry with a liquid‐filled electronic portal imaging device (1998) (7)
- Quantification of 11C-Laniquidar Kinetics in the Brain (2015) (7)
- Impact of Specific Crossing Techniques in Chronic Total Occlusion Percutaneous Coronary Intervention on Recovery of Absolute Myocardial Perfusion. (2019) (7)
- First Evaluation of [11C]R116301 as an In Vivo Tracer of NK1 Receptors in Man (2009) (7)
- Effect of Shortening the Scan Duration on Quantitative Accuracy of [18F]Flortaucipir Studies (2021) (6)
- [18F]FDG Uptake in Adipose Tissue Is Not Related to Inflammation in Type 2 Diabetes Mellitus (2020) (6)
- Use of an in-field-of-view shield to improve count rate performance of the single crystal layer high-resolution research tomograph PET scanner for small animal brain scans. (2003) (6)
- The approval of a disease-modifying treatment for Alzheimer’s disease: impact and consequences for the nuclear medicine community (2021) (6)
- Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum (2019) (6)
- Hippocampal [18F]flortaucipir BPND corrected for possible spill-in of the choroid plexus retains strong clinico-pathological relationships (2019) (6)
- Reply to: FDG PET and PET/CT: EANM procedure guideline for tumour PET imaging (2010) (6)
- 3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung: A Potential Biomarker for Pulmonary Arterial Hypertension (2018) (6)
- Updating PET/CT performance standards and PET/CT interpretation criteria should go hand in hand (2019) (6)
- Image properties of various ML-based reconstructions of very noisy HRRT data (2011) (6)
- Repeatability of parametric methods for [18F]florbetapir imaging in Alzheimer’s disease and healthy controls: A test–retest study (2020) (6)
- Letter to the Editor re: Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake (2019) (6)
- A dual-time-window protocol to reduce acquisition time of dynamic tau PET imaging using [18F]MK-6240 (2021) (6)
- 18F-FDG PET Improves Baseline Clinical Predictors of Response in Diffuse Large B-Cell Lymphoma: The HOVON-84 Study (2021) (6)
- Impact of New Scatter Correction Strategies on High-Resolution Research Tomograph Brain PET Studies (2016) (6)
- Reply: Simplified Methods for Quantification of 18F-Fluoromethylcholine Uptake: Is SUVAUC,PP Actually an SUV? (2015) (6)
- Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features (2022) (6)
- 286 Tumor targeting and tissue biodistribution of RO7122290, a novel FAP-targeted 4–1BB (CD137) agonist, in patients with advanced solid tumors, using [89Zr]-RO7122290 as a PET tracer (2020) (6)
- Primary tumor volume measurements in Ewing sarcoma: MRI inter- and intraobserver variability and comparison with FDG-PET (2017) (6)
- Molecular markers of Alzheimer's Disease pathology and their relationship with default mode network integrity (2011) (6)
- Evaluation of a 3D iterative reconstruction algorithm that allows for negative image values in high resolution pet studies (2009) (5)
- Performance Evaluation of a Semi-automated Method for [18F]FDG Uptake in Abdominal Visceral Adipose Tissue (2019) (5)
- Early 18F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer (2016) (5)
- Intervention versus standard medical treatment in patients with symptomatic occlusion of the internal carotid artery: a randomised oxygen-15 PET study (2013) (5)
- Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET (2021) (5)
- The Optimal Timing of Interim 18F-FDG PET in Diffuse Large B-Cell Lymphoma: An Individual Patient Data Meta-Analysis By the Petra Consortium (2019) (5)
- Pharmaceutical preparation of oxygen‐15 labelled molecular oxygen and carbon monoxide gasses in a hospital setting (2010) (5)
- Whole-body parametric PET imaging will replace conventional image-derived PET metrics in clinical oncology. (2018) (5)
- Episodic memory in mild cognitive impairment inversely correlates with the global modularity of the cerebral blood flow network (2018) (5)
- P2-201 Microglia activation in mild cognitive impairment (2004) (5)
- Influences on PET Quantification and Interpretation (2022) (5)
- Development of a tracer kinetic model for the analysis of (R)-[11C]verapamil data (2005) (5)
- 89Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer (2022) (5)
- Performance of nanoScan PET/CT and PET/MR for quantitative imaging of 18F and 89Zr as compared with ex vivo biodistribution in tumor-bearing mice (2021) (5)
- Optimization of parathyroid 11 C-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism (2019) (5)
- Quantification of dynamic brain studies with the high resolution research tomograph (2004) (5)
- First-time imaging of [89Zr]trastuzumab in breast cancer using a long axial field-of-view PET/CT scanner (2022) (5)
- Interobserver Agreement on Automated Metabolic Tumor Volume Measurements of Deauville Score 4 and 5 Lesions at Interim 18F-FDG PET in Diffuse Large B-Cell Lymphoma (2021) (4)
- Effects of Reusing Baseline Volumes of Interest by Applying (Non-)Rigid Image Registration on Positron Emission Tomography Response Assessments (2014) (4)
- EORTC Imaging Group (2012) (4)
- Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's disease (2016) (4)
- Parametric Imaging of [ 11 C ] Flumazenil Binding in the Rat Brain (2017) (4)
- Diagnostic Performance of [18F]FDG PET in Staging Grade 1–2, Estrogen Receptor Positive Breast Cancer (2021) (4)
- Standardised lesion segmentation for imaging biomarker quantitation: a consensus recommendation from ESR and EORTC (2022) (4)
- Quantification of 18F‐DCFPyL Uptake: TBR versus Patlak’s Analysis. (2019) (4)
- Peroperative neuromonitoring during carotid endarterectomy in relation to preoperative positron emission tomography findings. (2008) (4)
- [11C]flumazenil kinetics in the rat brain: model preference and the impact of non-specific and non-selective binding in reference region modeling (2016) (4)
- 18 F-FDG PET standard uptake values of the normal pons in children: establishing a reference value for diffuse intrinsic pontine glioma (2014) (4)
- Direct comparison of [11C] choline and [18F] FET PET to detect glioma infiltration: a diagnostic accuracy study in eight patients (2019) (4)
- Feasibility of pharmacokinetic parametric PET images in scaled subprofile modelling using principal component analysis (2021) (4)
- Validation of [18F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor (2018) (4)
- Textural Feature Based Segmentation: A Repeatable and Accurate Segmentation Approach for Tumors in PET Images (2020) (4)
- ORIGINAL ARTICLE Quantification of ( 18 F)DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients (2015) (4)
- Reply to: Area under the cumulative SUV-volume histogram is not a viable metric of intratumoral metabolic heterogeneity (2013) (4)
- Impact of partial volume corrections on quantitative brain PET studies (2012) (4)
- Quantification of the neurokinin 1 receptor ligand [11C]R116301 (2011) (4)
- Repeatability of metabolically active tumor volume of [18F]FDG PET-CT in a multicenter setting (2013) (4)
- Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease (2019) (4)
- Accuracy of 3D acquisition mode for myocardial FDG PET studies using a BGO-based scanner (2007) (4)
- Head-to-head comparison of (R)-[11C]verapamil and [18F]MC225 in non-human primates, tracers for measuring P-glycoprotein function (2021) (4)
- Arterial wall inflammation in rheumatoid arthritis is reduced by anti-inflammatory treatment. (2021) (4)
- Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor (2022) (4)
- Initial experience with a prototype dual-crystal (LSO/NaI) dual-head coincidence camera in oncology (2004) (4)
- P964Relationships between extent of ischemic burden and changes in absolute myocardial perfusion after chronic total occlusion percutaneous coronary intervention (2019) (4)
- 18FDG SUV in the primary tumor and lymph node metastases is not predictive for development of distant metastases in high risk head and neck cancer patients. (2015) (4)
- Multiparametric analysis of the relationship between tumor hypoxia and perfusion using 18F-FAZA and 15O- H2O PET (2015) (4)
- Prediction of Non-Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients with 18F-FDG PET Radiomics Based Machine Learning Classification (2022) (4)
- Impact of image processing on [11C]PIB amyloid quantification (2019) (4)
- Parametric Method Performance for Dynamic 3′-Deoxy-3′-18F-Fluorothymidine PET/CT in Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Carcinoma Patients Before and During Therapy (2017) (4)
- IC-P3-224: Regional variations in age dependence of P-gp mediated transport across the blood-brain barrier measured using (R)-[11C]verapamil and positron emission tomography (2008) (3)
- Baseline PET as prognostic marker for Hodgkin? (2018) (3)
- ImmunoPET imaging with 89Zr-cetuximab in patients with advanced colorectal cancer. (2014) (3)
- Amyloid burden quantification depends on PET and MR image processing methodology (2021) (3)
- First Evaluation of [ 11 C ] R 116301 as an In Vivo Tracer of NK 1 Receptors in Man (2009) (3)
- Imaging beta amyloid deposition in vivo: Quantitative comparison of [18F]FDDNP and [11C]PIB (2007) (3)
- Effect of reconstruction settings and therapy on F-18-FDG PET/CT blood pool and liver SUV in patients with diffuse large B-cell lymphoma (2017) (3)
- Potential and pitfalls of 89Zr-immuno-PET to assess target status: 89Zr-trastuzumab as an example (2021) (3)
- Effects of reference tissue versus plasma input parametric kinetic modelling on statistical parametric analysis of [11C](R)-PK11195 binding in Alzheimer's disease (AD) and young and old subjects (2005) (3)
- Test-retest variability of a cumulative SUV-volume histogram method for quantification of FDG uptake heterogeneity (2012) (3)
- Impact of wavelet based denoising of [11C](R)-PK11195 time activity curves on accuracy and precision of kinetic analysis. (2008) (3)
- Multi-input spectral analysis for evaluation of the contribution of radioactive metabolites in (R)-[11C]verapamil PET data (2005) (3)
- Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma (2020) (3)
- Evaluation of reference tissue models for analysing [11C](R)-PK11195 studies (2005) (3)
- P1.04-12 Tumor Uptake and Biodistribution of 89Zr-Labeled Pembrolizumab in Patients with Metastatic Non-Small-Cell Lung Cancer (2019) (3)
- Correction to: Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers (2021) (3)
- Volume of interest delineation techniques for 18F-FDG PET-CT scans during neoadjuvant extremity soft tissue sarcoma treatment in adults: a feasibility study (2018) (3)
- Biodistribution of 18F-FES in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (G1T48), a Novel Selective ER Degrader (2021) (3)
- Quantitative Assessment of Arthritis Activity in Rheumatoid Arthritis Patients Using [11C]DPA-713 Positron Emission Tomography (2020) (3)
- 124 I and 89 Zr compared to 18 F (2005) (3)
- Why Is Amyloid-β PET Requested After Performing CSF Biomarkers? (2019) (3)
- Microglia activation in recent onset schizophrenia: a quantitative (R)-[11C]PK11195 PET study (2008) (3)
- Standardised Uptake Values as Determined on PSMA PET/CT is associated with Oncological Outcomes in Prostate Cancer Patients. (2022) (3)
- RESTING STATE CEREBRAL PERFUSION AND METABOLISM IN SUBJECTIVE MEMORY COMPLAINTS: ALZHEIMER'S DISEASE AND FRONTOTEMPORAL DEMENTIA–TWO SIDES OF THE SAME COIN? (2014) (3)
- Kinetic analysis in human brain of 11C-(R)-rolipram, a PET tracer of the cAMP cascade: Test-retest study and the use of an image-derived input function (2010) (3)
- Quality control in PET/CT and PET/MRI: Results of a survey amongst European countries. (2022) (3)
- Evaluation of the Effect of Magnetic Field on PET Spatial Resolution and Contrast Recovery Using Clinical PET Scanners and EGSnrc Simulations (2015) (3)
- In vivo tracking of single cells with PET (2020) (3)
- Prediction of functional recovery after revascularization in patients with chronic ischemic myocardial dysfunction: perfusable tissue index by positron emission tomography and contrast-enhanced MRI comparison study (2011) (3)
- Synthesis and pet‐studies of (R)‐and (S)‐[11C]verapamil for measuring PGP function in MDR1A(+/+)/B(+/+) and MDR1A(‐/‐)/B(‐/‐) mice (2001) (3)
- Pancreatic Uptake by 18F-FDOPA PET/CT in Patients With Hypoglycemia After Gastric Bypass Surgery Compared With Controls With or Without Carbidopa Pretreatment (2017) (3)
- Assessment of Tumour Volume in Lung Cancer: PET versus CT based Methods (2010) (2)
- Correction for emission contamination in transmission scans for the High Resolution Research Tomograph (2003) (2)
- Interlesional Heterogeneity of Metastatic Neuroendocrine Tumors Based on 18F-DOPA PET/CT. (2019) (2)
- Cerebral amyloid angiopathy in Alzheimer’s disease is associated with increased blood-brain barrier permeability: A quantitative [11C]PiB-PET study (2013) (2)
- OC-020: Non Invasive PET Imaging of Cetuximab-Zirconium-89 Biodistribution: A Phase i Trial (2013) (2)
- The need for quantitative PET in multicentre studies (2014) (2)
- Parametric Methods for Dynamic 11C-Phenytoin PET Studies (2017) (2)
- Quantification of 18 F-fluorocholine kinetics in patients with prostate cancer (2015) (2)
- Interlesional Heterogeneity of Metastatic Neuroendocrine Tumors Based on 18F-DOPA PET/CT. (2019) (2)
- Dynamic PET Reconstruction Utilizing a Spatiotemporal 4D De-noising Kernel (2018) (2)
- Feasibility of brain PET/CT harmonization - a multicenter, multivendor pilot study (2018) (2)
- Cerebral blood flow, amyloid burden, and cognition in cognitively normal individuals (2022) (2)
- Population-based input function is an accurate alternative to arterial sampling in [11C](R)-rolipram PET brain studies (2011) (2)
- Relationship of cerebrospinal fluid biomarkers with in vivo [11C]PIB and [18F]FDDNP binding (2009) (2)
- Metabolically active tumour volume segmentation from dynamic [18F]FLT PET studies in non-small cell lung cancer (2015) (2)
- Selection of a reference tissue region for [11C](R)-PK11195 studies in Alzheimer's disease (2006) (2)
- Investigation of the dosimetric characteristics of a liquid-filled electronic portal imaging device (1995) (2)
- Multiparametric Analysis of the Relationship Between Tumor Hypoxia and Perfusion with 18 F-Fluoroazomycin (2016) (2)
- First ever longitudinal [11C]PIB and [18F]FDDNP PET studies in patients with Alzheimer's disease or mild cognitive impairment and healthy controls (2010) (2)
- Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer’s disease (2022) (2)
- Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer 18F-FDG PET Radiomics (2021) (2)
- EVENT-BASED MODELING OF THE TEMPORAL ORDERING OF REGIONAL β-AMYLOID DEPOSITION IN THE BRAIN (2018) (2)
- Changes in benzodiazepine receptor binding in Dutch veterans with posttraumatic stress disorder assessed with [C-11]-flumazenil and PET (2005) (2)
- Impact of reconstruction algorithms on the repeatability of various PET/CT radiomics features in lung cancer patient (2015) (2)
- SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden (2021) (2)
- An automatic delineation method for bone marrow absorbed dose estimation in 89Zr PET/CT studies (2016) (2)
- Whole body PD-L1 PET in patients with NSCLC and melanoma. (2018) (2)
- Quantitative Issues in Response Measurement by PET. (2008) (2)
- Differential impact of apolipoprotein E genotype on distributions of amyloid load and glucose metabolism in Alzheimer's disease (2012) (2)
- Head to head comparison of (R)-[11C]verapamil and [18F]MC225 in non-human primates; tracers for measuring P-gp function at the blood-brain barrier (2017) (2)
- Quanti fi cation of [ 18 F ] DPA-714 binding in the human brain : initial studies in healthy controls and Alzheimer ’ s disease patients (2015) (2)
- Performance characteristics and quantitative clinical evaluation of the digital Siemens Biograph Vision PET/CT (2019) (2)
- 2-[18F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee (2022) (2)
- A more optimal initial attenuation image estimate in TOF-MLAA reconstruction for PET/MR (2015) (2)
- F-FDG-PET uptake in non-infected total hip prostheses (2018) (2)
- Longitudinal amyloid imaging using [11]PIB: Choosing the right method (2011) (2)
- PET/CT and PET/MR Tomographs: Image Acquisition and Processing (2019) (2)
- Reply: Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures in Patients with Non–Small Cell Lung Cancer: Dynamic Versus Test–Retest Design (2017) (2)
- Should vascular wall 18F-FDG uptake be adjusted for the extent of atherosclerotic burden? (2020) (2)
- Correction to: [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer (2020) (2)
- Comparison of various models for analysing [11C]flumazenil studies (2005) (2)
- Two decades at the cross-roads of biology, physics and epidemiology: lessons learned in [18F-]FDG positron emission tomography in oncology. (2010) (2)
- Deep Learning Based Approach to Quantification of PET Tracer Uptake in Small Tumors (2019) (2)
- Correction: Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer's disease PET studies (2019) (2)
- Baseline and longitudinal variability of normal tissue uptake values of [18F]-fluorothymidine-PET images. (2017) (2)
- Study of 89 Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non – Small Cell Lung Cancer (2022) (2)
- EVENT-BASED MODELING OF THE TEMPORAL ORDERING OF REGIONAL β-AMYLOID DEPOSITION IN THE BRAIN (2018) (1)
- Obtaining cardiac images from positron emission tomography, computed tomography, and magnetic resonance imaging : physical principles (2007) (1)
- Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours – a clinical physics perspective (2016) (1)
- Artificial Intelligence in Nuclear Medicine: Opportunities, Challenges, and Responsibilities Toward a Trustworthy Ecosystem (2022) (1)
- 18 F-FDG-PET uptake in non-infected total hip prostheses (2018) (1)
- DNA methylation classification in diffuse glioma shows little spatial heterogeneity after adjusting for tumor purity (2020) (1)
- Longitudinal changes in specific [11C]PIB and [18F]FDDNP binding: Paired PET studies in patients with Alzheimer's disease, mild cognitive impairment and healthy controls (2011) (1)
- Cerebral amyloid angiopathy in Alzheimer’s disease is associated with increased blood-brain barrier permeability: A quantitative [11C]PiB-PET study (2013) (1)
- Validation of simplified uptake measures against dynamic Patlak Ki for quantification of lesional 89Zr-Immuno-PET antibody uptake. (2023) (1)
- Improving accuracy and precision of PET pharmacokinetic analysis using wavelet based denoising of time activity curves (2005) (1)
- Improved image derived input functions using Iterative deconvolution and HYPR denoising (2016) (1)
- Klumpers UM , Veltman DJ, Van Tol MJ, Kloet RW, Boellaard R, Lammertsma AA, Hoogendijk WJ. Neurophysiological effects of sleep deprivation in healthy adults. Submitted (2012) (1)
- PREDICTIVE VALUE OF QUANTITATIVE 18 F‐FDG‐PET‐CT RADIOMICS ANALYSIS IN 174 PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA (2021) (1)
- Effect of rigid and non-rigid image registration on test-retest repeatability of quantitative measures derived from FDG PET/CT oncology studies (2010) (1)
- Quantitative imaging in cancer: connecting cellular processes with therapy: Data and Image Analysis (WP4) (2013) (1)
- 89Zr labeled cetuximab imaging in colorectal cancer patients aimed at image-guided patient selection for anti-EGFR treatment (2014) (1)
- Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determination (2019) (1)
- Standardised uptake values as determined on prostate‐specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer (2022) (1)
- Qualitative and quantitative analyses of F-18-FES and F-18-FDHT uptake in patients with metastatic breast cancer: an interobserver variability study (2017) (1)
- Reply: Quantification of 18F-DCFPyL Uptake: TBR Versus Patlak’s Analysis (2019) (1)
- Precision estimates of relative and absolute cerebral blood flow in Alzheimer’s disease and cognitively normal individuals (2022) (1)
- New Scatter Correction Strategies on HRRT Studies (2017) (1)
- Accuracy of partial volume correction: CT versus PET for tumor volume definition (2007) (1)
- Shortened duration whole body 18F-FDG PET Patlak imaging on the Biograph Vision Quadra PET/CT using a population-averaged input function (2022) (1)
- Zr-immuno-PET: a multicenter analysis (2019) (1)
- A novel supervised watershed method for segmentation of tumors with heterogeneous tracer uptake in PET (2014) (1)
- Correction to: Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease (2020) (1)
- [18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant. (2023) (1)
- PD-0453: Test-retest repeatability analysis of 18F-FDG PET Radiomics features in NSCLC (2013) (1)
- Pharmacokinetic Modeling of (R)-[11C]verapamil to Measure the P-Glycoprotein Function in Nonhuman Primates (2020) (1)
- Correction to: EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3 (2022) (1)
- 18f-FDG PET/CT Baseline Rdiomics Features Improve the Prediction of Treatment Outcome in Diffuse Large B-Cell Lymphoma Patients (2020) (1)
- Magnetic field and PET: Does the effect of magnetic field vary with the intrinsic resolution of PET scanners? (2014) (1)
- Impact of quality assurance, centralized analysis, ROI method and glucose correction on SUV test-retest variability in a multi-center setting (2009) (1)
- Impact of kinetic model design on the analysis of dynamic [15O]O2 studies (2007) (1)
- Test-retest repeatability of quantitative [F-18]florbetapir studies in humans (2017) (1)
- Data-driven volume of interest definition: Benefits and pitfalls (2006) (1)
- EXPLORING THE EFFECT OF SOUVENAID ON CEREBRAL GLUCOSE METABOLISM IN EARLY ALZHEIMER’S DISEASE (2019) (1)
- Methodological aspects of PET/MR imaging (2013) (1)
- Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma (2022) (1)
- Quantitative accuracy of the High Resolution Research Tomograph: Experimental and clinical evaluation (2005) (1)
- Optimal imaging time points considering accuracy and precision of Patlak linearization for 89Zr-immuno-PET: a simulation study (2022) (1)
- Combatting the effect of image reconstruction settings on lymphoma [18F]FDG PET metabolic tumor volume assessment using various segmentation methods (2022) (1)
- Principles and Practice of PET/CT Part 1 (2010) (1)
- Non-invasive simplified metrics as a surrogate for validation of reference regions for [F-18] Flortaucipir and [F-18] Florbetapir brain PET studies (2019) (1)
- Visual assessment of parametric [11C]PiB images (2012) (1)
- Improving the signal-to-noise ratio in static PET reconstruction using HYPR-OSEM (2016) (1)
- EFOMP's protocol quality controls in PET/CT and PET/MR. (2022) (1)
- University of Groningen Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [F-18]FDG-PET/CT Studies (2016) (1)
- PO-0968: The effect of SUV discretization in PET Radiomics: the need for standardized methodology in tumor texture analysis (2015) (1)
- RATIONALE AND DESIGN OF THE NL-ENIGMA STUDY: A DUTCH 24-WEEK RANDOMISED CONTROLLED STUDY TO EXPLORE THE EFFECT OF NUTRITIONAL INTERVENTION ON BRAIN GLUCOSE METABOLISM IN EARLY ALZHEIMER DISEASE (2014) (1)
- Quantitative Accuracy of the HRRT in an Interscanner Study with the HR+ and (R)-[11C]verapamil (2010) (1)
- Binding characterization of N‐(2‐chloro‐5‐thiomethylphenyl)‐N′‐(3‐[3H]3methoxy phenyl)‐N′‐methylguanidine ([3H]GMOM), a non‐competitive N‐methyl‐D‐aspartate (NMDA) receptor antagonist (2019) (1)
- FDG standardized uptake value as prognostic factor for inoperable non-small cell lung cancer (2005) (1)
- Longitudinal change in ATN biomarkers in cognitively normal individuals (2022) (1)
- Cerebral C-11-PK11195 binding is significantly increased in patients with hepatitis C-cirrhosis but not in alcohol-toxic cirrhosis (2012) (1)
- Corrigendum: Primary tumor volume measurements in Ewing sarcoma: MRI inter- and intraobserver variability and comparison with FDG-PET (vol 57, pg 534, 2017) (2018) (1)
- Lifting wavelet transform for denoising PET time–activity curves: Effect on kinetic analyses (2006) (1)
- External validation: a simulation study to compare cross-validation versus holdout or external testing to assess the performance of clinical prediction models using PET data from DLBCL patients (2022) (1)
- Standardization of Imaging Biomarkers: The FDG PET/CT Example (2017) (1)
- Feasibility of deriving CBF, OEF and CMRO2 from a single dynamic PET scan using a short inhalation of oxygen-15 labelled molecular oxygen (2005) (1)
- P029: A Dutch 24-week randomised controlled study exploring the Effect of a Nutritional Intervention on brain Glucose Metabolism in early Alzheimer's disease (NL-ENIGMA) rationale and design (2014) (1)
- External validation of an MR-based radiomic model predictive of locoregional control in oropharyngeal cancer (2022) (1)
- The Netherlands protocol for standardization of FDG whole body PET studies in multi-center trials (NEDPAS) (2008) (1)
- Magnetic resonance imaging based radiomics prediction of Human Papillomavirus infection status and overall survival in oropharyngeal squamous cell carcinoma. (2023) (1)
- Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma (2022) (1)
- Meta-Analysis of the Test-Retest Repeatability of [18F]-Fluorodeoxyglucose Standardized Uptake Values: Implications for Assessment of Tumor Response. (2022) (1)
- A MR Guided De-noising for PET Using IHYPR-LR (2017) (1)
- Noise sensitivity of 89Zr-Immuno-PET radiomics based on count-reduced clinical images (2022) (1)
- Comparison of SUVs based on different ROIs and VOIs definitions: a multicenter respiratory phantom study (2016) (1)
- CHAPTER 3 Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U 36 in the detection of lymph node metastases in head and neck cancer patients (2019) (1)
- Correction to: Parametric Imaging of [11C]Flumazenil Binding in the Rat Brain (2018) (1)
- Impact of mis-matched TOF kernel in TOF-OSEM and TOF-MLAA reconstructions (2016) (1)
- Correction to: Letter to the Editor re: Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake (2020) (1)
- Effects of MR based attenuation correction on clinical interpretation and quantification of [18F]flutemetamol scans: A comparison between PET/CT and PET/MR (2015) (0)
- Early‐onset Alzheimer’s disease is related to differential spatial patterns of tau pathology and cognitive impairment (2020) (0)
- Performance evaluation of various parametric methods : For [11C]PIB (2007) (0)
- Use of image derived input functions for [11C]PIB studies : Assessment of accuracy and test-retest variability (2007) (0)
- Simplified dosimetry approaches for [89Zr] Mabs: Impact of manual and semi-automatic delineation methods (2014) (0)
- EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies (2018) (0)
- Evaluation of a Semi-automated Method for [ F-18 ] FDG Uptake in Abdominal Visceral Adipose Tissue (2019) (0)
- Kinetic analysis of the NMDA receptor ligand [11C]GMOM in men (2014) (0)
- Experimental assessment of PET/CT repeatability (2017) (0)
- Image Reconstruction Robustness of Radiomic Features in Lymphoma FDG PET/CT studies (2018) (0)
- Quantitative accuracy remains after shortening of dynamic [ 18 F]flortaucipir PET protocol: Neuroimaging / Optimal neuroimaging measures for tracking disease progression (2020) (0)
- [18F]FLORTAUCIPIR BINDING STRONGLY CORRELATES TO COGNITION ACROSS THE CLINICAL ALZHEIMER’S DISEASE CONTINUUM, INDEPENDENTLY OF CSF TAU (2019) (0)
- Optimization of the k2’ parameter for the pharmacokinetic modelling of dynamic PIB scans using SRTM2 (2018) (0)
- Standardized uptake values are adequate measures of [18F]DCFPyL PSMA PET/CT uptake in patients with low prostate cancer disease burden (2020) (0)
- Partial volume correction strategies for quantification of FDG whole body studies (2008) (0)
- Assessment of microglial activation in patients with Alzheimer's disease using [C-11]-(R)-PK11195 and PET (2005) (0)
- Evaluation of a list-mode TOF-MLAA reconstruction with a magnitude preconditioning using GATE (2016) (0)
- Visceral adipose tissue volume is associated with F-18-FDG-PET assessed arterial inflammation in male patients with early type 2 diabetes (2017) (0)
- EFOMP and EANM: joint recommendations for a curriculum for the education and training of physicists in nuclear medicine (2013) (0)
- Dopaminergic activity in Tourette's syndrome and obsessive–compulsive disorder (2010) (0)
- Image derived input functions for dynamic HRRT brain studies (2008) (0)
- Prolonged increased and widespread (R)-[11C]PK11195 binding after human traumatic brain injury (2010) (0)
- EARLY TAU PET PATHOLOGY IS ASSOCIATED WITH MEMORY PERFORMANCE IN COGNITIVELY UNIMPAIRED INDIVIDUALS WITH SCD: THE SCIENCE PROJECT (2019) (0)
- Utility of PET in Pharmaceutical Development (2012) (0)
- FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: Joint procedural recommendation of the EANM, SNMMI, the PET Interest Group (PIG), and endorsed by the ASNC Writing group*: (2018) (0)
- Repeatability of 18F-FDG PET/CT total metabolic active tumor volume and total tumor burden assessment in NSCLC patients: impact of acquisition, image reconstruction and delineation method. (2018) (0)
- Precision estimates of Relative and Absolute Cerebral Blood Flow in Alzheimer’s disease and Cognitively Normal individuals (2022) (0)
- University of Groningen Tumour necrosis as assessed with F-18-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements (2019) (0)
- Radiation dose of [18F]DPA714 PET studies (2011) (0)
- RATIONALE AND DESIGN OF THE NL-ENIGMA STUDY, A DUTCH 24-WEEK RANDOMISED CONTROLLED STUDY TO EXPLORE THE EFFECT OF A NUTRITIONAL INTERVENTION ON BRAIN GLUCOSE METABOLISM IN EARLY ALZHEIMER'S DISEASE (2014) (0)
- Development of longitudinal PET studies for experimental animal models (2005) (0)
- BrainPET Poster Session: PET Acquisition and Processing (2009) (0)
- EXTENSION AND VALIDATION OF AN AMYLOID STAGING MODEL: ASSOCIATIONS WITH CLINICAL MEASURES (2018) (0)
- Detecting Alzheimer pathology in vivo: Comparing regional binding of [11C]PIB and [18F]FDDNP (2008) (0)
- Tumor Microenvironment Composition Correlates with Quantitative 18F-FDG PET-CT Features and Serum TARC in Patients with Relapsed or Refractory Hodgkin Lymphoma (2022) (0)
- Can relative flow derived from dynamic 11C-PIB scans replace FDG scans in Alzheimer disease PET studies? (2017) (0)
- Regional distribution of tau pathology in cognitively unimpaired, genetically identical twins (2020) (0)
- Myocardial O2 supply and O2 utilization of the right ventricle in pulmonary arterial hypertension (2012) (0)
- Measurement of regional pulmonary ventilation and perfusion using gated PET (2010) (0)
- Reproducibility of tumor perfusion measurements using [15O]H2O and PET (2008) (0)
- Strategies to reduce sample sizes in Alzheimer’s disease primary and secondary prevention trials using longitudinal amyloid PET imaging (2021) (0)
- PARAMETRIC IMAGING OF TAU LOAD IN ALZHEIMER’S PATIENTS AND CONTROLS USING FLORTAUCIPIR (2017) (0)
- A Case-Based Approach to PET/CT in Oncology: Methodological aspects of therapeutic response evaluation with FDG-PET (2012) (0)
- PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel–carboplatin–bevacizumab with or without nitroglycerin: 158P (2016) (0)
- Combined microdialysis and longitudinal (R)-[11C]PK11195 PET study (2010) (0)
- Alzheimer’s disease pattern derived from relative cerebral flow as an alternative for the metabolic pattern using SSM/PCA (2022) (0)
- Baseline PET radiomics outperform the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma. (2023) (0)
- On the validity of reference tissue models for analysing (R)-[11C]PK11195 studies in traumatic brain injury (2007) (0)
- European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours. (2023) (0)
- LONGITUDINAL DYNAMIC [18F]FLORTAUCIPIR PET REVEALS INCREASED EARLY STAGE TAU PATHOLOGY IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE (2019) (0)
- UvA-DARE ( Digital Academic Repository ) FDG PET and PET / CT : EANM procedure guidelines for tumour PET imaging : version 1 . 0 (2018) (0)
- PO-0953 Are quality assurance phantoms useful to assess radiomics reproducibility? A multi-center study (2019) (0)
- RT2009 Conference Record Template (2018) (0)
- Quantitative accuracy remains after shortening of dynamic [18F]flortaucipir PET protocol (2020) (0)
- O26. A review on target volume delineation using FDG-PET/CT images for radiation oncology (2016) (0)
- Evaluation of partial volume corrections for (R)-[C-11]PK11195 studies (2007) (0)
- Visual assessment of parametric [11C]PIB images (2012) (0)
- Harmonisation of PET/CT Performance for Brain Studies (2019) (0)
- Discordant amyloid-β PET and CSF biomarkers and its clinical consequences (2019) (0)
- LONGITUDINAL DYNAMIC [18F]FLORTAUCIPIR PET REVEALS INCREASED EARLY STAGE TAU PATHOLOGY IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE (2019) (0)
- EANM / EANO / RANO practice guidelines / SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [ F-18 ] FDG (2019) (0)
- Alterations in GABAA receptor kinetics in epileptic rats studied in vivo using positron emission tomography (2006) (0)
- [I122] Quantitative molecular imaging: Can we trust the SUV? (2018) (0)
- Microglia activation after traumatic brain injury (2006) (0)
- Determining the optimal segmentation method for assessing metabolic tumor volume in (18)FDG-PET-CT scans in relapsed/refractory classical Hodgkin lymphoma (2019) (0)
- SP-0015: How to make PET more quantitative (PET QA) (2013) (0)
- MIMEB: A phase II trial to evaluate FDG-PET/FLT-PET and DCE-MRI for early prediction of efficacy in patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab. (2012) (0)
- SEMI-AUTOMATED AI BASED ORGAN DELINEATION ON LOW DOSE CT TO FACILITATE PET RADIOTRACER BIODISTRIBUTION MEASUREMENTS (2022) (0)
- Alzheimer's disease pattern derived from pharmacokinetic modeling of 11C-Pittsburgh compound B PET scans (2019) (0)
- Parametric imaging of [C]flumazenil binding in the rat brain (2017) (0)
- 18 FDG ( Fluoro-2-Deoxyglucose) Uptake in Esophageal Cancer: Linking Biology and Outcome (2007) (0)
- 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer (2018) (0)
- Repeatability of Two Artificial Intelligence Approaches for Tumor Segmentation in PET (2020) (0)
- Arterial Wall Inflammation Declines after 6 Months of Anti-Inflammatory Therapy with Methotrexate and/or Adalimumab in Rheumatoid Arthritis Patients (2018) (0)
- Radiomics from [ 18 F]PSMA PET-CT with machine learning as a novel biomarker in primary prostate cancer (2019) (0)
- MP26-04 STANDARDIZED UPTAKE VALUES AS DETERMINED ON PROSTATE-SPECIFIC MEMBRANOUS ANTIGEN POSITRON EMISSION TOMOGRAPHY/COMPUTER TOMOGRAPHY ARE ASSOCIATED WITH GLEASON GRADE AND BIOCHEMICAL RECURREANCE OF DISEASE IN PATIENTS WITH PROSTATE CANCER (2021) (0)
- Use of image derived input functions for [11C]PIB, (R)-[11C]verapamil and (R)-[11C]PK11195 brain studies: Assessment of accuracy and test–retest variability (2008) (0)
- Do high resolution protocols improve lesion detectability in PET/CT? (2014) (0)
- Validation of reference regions for [F-18]Flortaucipir and [F-18]Florbetapir brain PET studies using non-invasive simplified metrics (2019) (0)
- Parametric methods for quantification of [11C]Flumazenil studies (2010) (0)
- Feasibility of a phantom with 3D printed inserts with realistic uptake patterns to study the performance of radiomics features (2018) (0)
- Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter study (2017) (0)
- Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphoma (2022) (0)
- Partial volume corrected image derived input functions for kinetic modelling of FDG PET brain studies (2019) (0)
- Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients (2009) (0)
- Biodistribution of [18F]FES in patients with metastatic ER+ breast cancer undergoing treatment with the novel selective estrogen receptor degrader G1T48 (2020) (0)
- Non-invasive quantification of 11C-hydroxyephidrine: Alternatives for arterial metabolite corrections (2013) (0)
- Reply: Should we assess repeatability of PET quantitative uptake measurements of each 18F-labelled tracer? (2018) (0)
- CHAPTER 6 METABOLIC ACTIVITY MEASURED BY FDG PET PREDICTS PATHOLOGIC RESPONSE IN LOCALLY ADVANCED SUPERIOR SULCUS NSCLC (2014) (0)
- University of Groningen Quantification , improvement , and harmonization of small lesion detection with state-ofthe-art PET (2017) (0)
- Advanced glioma and correlation with histological and molecular characteristics (2013) (0)
- Feasibility of a brain PET harmonization program for state of the art PET/CT systems (2017) (0)
- EVENT-BASED MODELING OF THE TEMPORAL ORDERING OF REGIONAL b -AMYLOID DEPOSITION IN THE BRAIN PET IMAGING OF SYNAPTIC DENSITY (SYNAPTIC VESICLE GLYCOPROTEIN 2A, SV2A)INALZHEIMER’S DISEASE:INITIAL (2018) (0)
- Multicenter quantitative assessment of treatment response by FDG PET/CT (2014) (0)
- Comparison of HRRT and HR+ scanners for quantitative brain studies using (R)-[11C]verapamil and [11C]raclopride (2012) (0)
- Implementation of physiological gating on the high resolution research tomograph (2008) (0)
- Standardized quantitative characterization of PET/CT scanners (2014) (0)
- Brain PET Oral 1: PET Image Reconstruction and Processing (2009) (0)
- Use of population input functions for FDG whole-body Patlak imaging (2020) (0)
- Early Response Monitoring of Erlotinib and Sorafenib by 18F-Fluorodeoxygluose and 15O-Water Positron Emission Tomography in Non-Small Cell Lung Cancer (2010) (0)
- Developments in oncological positron emission tomography/computed tomography assessment. (2015) (0)
- SUV analysis underestimates antitumor activity of a new drug (2009) (0)
- Parent fraction estimation methods for improved dynamic [C-11]PiB PET quantification (2018) (0)
- Classification of [F-18]Florbetapir brain PET studies in cognitively normal subjects using a Convolutional Neural Network (2019) (0)
- Regional tau pathology is associated with loss of synapses and reduced synaptic activity: A combined [18F]flortaucipir, [11C]UCB‐J and magnetoencephalography study (2020) (0)
- Validation of parametric analysis of dynamic [18F]FLT PET in EGFR-mutated NSCLC patients prior and during therapy. (2015) (0)
- 3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body 18F-Fluorodeoxyglucose and 89Zr-Rituximab PET Scans (2022) (0)
- Kinetics and 28 day test-retest repeatability and reproducibility of [C-11]UCB-J brain PET imaging (2019) (0)
- P4-305 IMPACT OF SIMVASTATIN ON CEREBRAL BLOOD FLOW, PULSATILITY INDEX, AND ALZHEIMER’S DISEASE BIOMARKERS: A CLINICALTRIAL (0)
- O1-03-01 Microglial activation in patients with mild cognitive impairment and Alzheimer’s disease: A study using [11C](R)-PK11195 and PET (2006) (0)
- PET segmentation of bulky tumors: inter-observer variability of four segmentation approaches (2018) (0)
- Quantitative assessment of joints affected by rheumatoid arthritis using [ 11 C]DPA713 PET (2019) (0)
- [18F]AV1451 PET IN RELATION TO ATROPHY ACROSS THE ALZHEIMER’S DISEASE SPECTRUM (2018) (0)
- Prolonged microglia activation after human traumatic brain injury: a longitudinal [11C]- (R)-PK11195 positron emission tomographic study (2008) (0)
- Comparison of 15O-H2O PET perfusion studies using an ECAT Exact HR+ stand-alone PET and a Gemini TF PET/CT system (2011) (0)
- Evaluation of HYPR-OSEM Using Experimental Phantom and Clinical Patient Data (2017) (0)
- Efficacy of [18F]FDG PET/CT in staging low-intermediate grade, estrogen receptor positive breast cancer : Staging with [18F]FDG PET/CT (2019) (0)
- Poster #117 NEUROINFLAMMATION IN TEMPORAL CORTEX OF PATIENTS WITH RECENTONSETSCHIZOPHRENIA (2012) (0)
- FLT PET depicts heterogeneous proliferation pathology in IPAH patient lung: a potential biomarker for PAH (2018) (0)
- Baseline Metabolic Tumor Volume in 18FDG-PET-CT Scans in Classical Hodgkin Lymphoma Using Semi-Automatic Segmentation (2019) (0)
- Evaluation of a more optimal initial attenuation image estimate in TOF-MLAA for PET/MR (2015) (0)
- The mutuality and robustness of radiomics features in [18F]FDG PET/CT lung cancer studies (2015) (0)
- Chapter 4 Experimental assessment of PET / CT repeatability (2017) (0)
- QUANTIFICATION OF TAU LOAD USING [18F]AV-1451 AND PET (2016) (0)
- When can image-derived input function be used in neuroreceptor PET brain studies? (2011) (0)
- Simulating the effect of cerebral blood flow changes on quantification of [F-18]flutemetamol and [F-18]florbetaben studies (2019) (0)
- Erratum to: Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis (2015) (0)
- Plasma to blood ratio derived parent fractions for robust plasma input based kinetic analysis of dynamic 18F-FLT PET studies in NSCLC cancer patients (2017) (0)
- MIMEB: A phase II trial to evaluate FDG-PET/FLT-PET, DCE-MRI and molecular biomarkers for early prediction of nonprogression in patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab. (2014) (0)
- Evaluation of [C-11]R116301 as a PET tracer of the NK1 receptor: A test-retest study in human subjects (2007) (0)
- [11C]phenytoin quantification (2017) (0)
- Increased [11C]PET And [18F]FDDNP Binding Are Selectively Associated With Memory Impairment (2009) (0)
- University of Groningen Imaging hormone receptors in metastatic breast cancer patients (2018) (0)
- [18F]AV1451 PET IN RELATION TO ATROPHY ACROSS THE ALZHEIMER’S DISEASE SPECTRUM (2018) (0)
- Accuracy and precision of parametric analysis of dynamic [18F]FLT PET in NSCLC patients. (2016) (0)
- THU0143 Vascular wall inflamation in rheumatoid arthritis patients decreases after 6 months of anti-inflammatory therapy with methotrexate or adalimumab as measured by 18f-fdg-pet/ct (2018) (0)
- University of Groningen Visceral adipose tissue volume is associated with premature atherosclerosis in early type 2 diabetes mellitus independent of traditional risk factors Reijrink, (2019) (0)
- Chapter 5 [ 11 C ] phenytoin quantification (2017) (0)
- Chapter 2 Comparison of HRRT and HR + Scanners (2017) (0)
- Cognitive performance in multiple sclerosis: what is the role of the GABAergic system? (2023) (0)
- Microglial activation in healthy aging (2010) (0)
- Standardized uptake values as determined on PSMA PET/CT are associated with higher Gleason grade and lower biochemical-free recurrence rates in patients with prostate cancer (2021) (0)
- EP-1682: Comparison of SUV based on different ROIs and VOIs definitions: a multi-center 4D phantom study (2017) (0)
- [18F]FLORBETAPIR SPECIFIC BINDING IN RELATION TO COGNITION IN SUBJECTIVE COGNITIVE DECLINE (2018) (0)
- Increased microglial activation in MCI and AD: An (R)-[11C]PK11195 PET study (2010) (0)
- Does 18F-Fluorodeoxyglucose Outperform 18F-Fluorothymidine When Using Positron Emission Tomography in Predicting Transformation of Indolent Non-Hodgkin's Lymphoma, (2011) (0)
- Parametric images of [11C]Flumazenil binding: Comparison of methods (2006) (0)
- PARAMETRIC IMAGING OF [18F]FLORBETAPIR: A TEST-RETEST STUDY IN HEALTHY SUBJECTS AND PATIENTS WITH ALZHEIMER’S DISEASE (2018) (0)
- Category: Methodology: Quantification and test–retest study of 11C-(R)-rolipram, a PET tracer of the cAMP cascade, using an arterial input function and an image-derived input function (2010) (0)
- In how many kinetic classes can [11C]-(R)-PK11195 brain PET data be segmented? (2008) (0)
- A STUDY TO EVALUATE THE KINETICS AND 28 DAY TEST-RETEST REPEATABILITY AND REPRODUCIBILITY OF THE RADIOLIGAND [11C]UCB-J FOR BRAIN PET IMAGING IN HEALTHY SUBJECTS AND MILD-MODERATE ALZHEIMER’S DISEASE SUBJECTS (2019) (0)
- Metabolic tumour volume assessments using static versus dynamic FDG PET studies (2011) (0)
- Abstract 1415: Staging with [18F]FDG PET/CT (2019) (0)
- Evaluation of SRW-OSEM Using Clinical Data (2017) (0)
- Automatic definition of image-derived input functions in brain PET images using clustering based on population arterial blood curves (2006) (0)
- Chapter 3 New Scatter Correction Strategies on HRRT Studies (2017) (0)
- Effects of boundary conditions in TOF-MLAA reconstruction for PET/MR (2015) (0)
- 6 speaker: How to Image Quantitatively? State of the Art and Future Equipment Development (2010) (0)
- Impact of scan statistics on accuracy, repeatability and lesion detectability of whole body [F-18]-FDHT PET-CT in metastatic castration resistant prostate CANCER (2019) (0)
- Validation of an image derived input function for non-invasive quantification of 11C-hydroxyephidrine (2013) (0)
- Quality Visits: The EANM/EARL FDG-PET/CT Accreditation Programme (2017) (0)
- AB1007 Increased Vascular Wall Inflammation in Patients with Active Rheumatoid Arthritis as Measured by an 18F-Fdg-Pet/Ct Scan (2014) (0)
- Change in metabolic tumor activity on F-18-FDG PET after a single dose of cetuximab to predict for treatment benefit, PFS, and OS in patients with advanced colorectal cancer. (2017) (0)
- LONG‐TERM FOLLOW‐UP AND BIOMARKER ANALYSES OF BRENTUXIMAB VEDOTIN AND DHAP IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENTS: THE HOVON/LLPC TRANSPLANT BRAVE STUDY (2021) (0)
- Impact of non-rigid and local rigid image registration on PET/CT response assessments (2011) (0)
- PD-0328 DOES PARTIAL VOLUME EFFECT IN PET AFFECT BIOLOGICALLY ADAPTED PLANNING BASED ON FDG UPTAKE? (2012) (0)
- Relation between 18FDG-PET standardised uptake values and prognosis in oesophageal cancer patients (2006) (0)
- P.3.f.007 Microglia is widespread activated in recent onset schizophrenia: evidence from PET and post mortem studies (2009) (0)
- Poster #T243 [11C]GMOM AS NEW POTENTIAL PET RADIOTRACER TO IMAGE THE NMDA RECEPTOR IN VIVO (2014) (0)
- KD in vivo by positron emission tomography (2008) (0)
- Kinetic modeling of [11C]laniquidar in human brain - A novel PET tracer for P-gp expression (2012) (0)
- Estimation of image derived input functions using a reconstruction based partial volume correction algorithm : Methodology and evaluation in [11C]flumazenil studies (2007) (0)
- Longitudinal [18F]flortaucipir PET: Comparison of quantitative and semi‐quantitative parameters (2021) (0)
- Reply to LTE: Automated segmentation of TMTV in DLBCL patients: what about method measurement uncertainty? (2020) (0)
- Reproducibility of 'metabolically active volume' measurements with 18F-FDG and 18F-FLT PET (2009) (0)
- University of Groningen Parametric Imaging of [ 11 C ] Flumazenil Binding in the Rat Brain (2017) (0)
- Improved FDG activity regimen for whole body FDG-PET imaging (2012) (0)
- SP-0215: Things radiotherapy physicists need to know about good PET imaging practice (2018) (0)
- Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP (2022) (0)
- Reproducibility of quantitative measurements with [18F]FLT-PET (2008) (0)
- A multi-label CNN model for the automatic detection and segmentation of gliomas using [18F]FET PET imaging. (2023) (0)
- Gaussian and point spread function filtering on a Philips Ingenuity TF-128 PET/CT scanner (2014) (0)
- Pharmacokinetic modelling of PET tracers in oncology (2013) (0)
- In vivo tau pathology is associated with synaptic loss and altered synaptic function (2021) (0)
- Repeatability of various PET/CT radiomics features extracted from metastasized livers of patients with colorectal carcinoma (2014) (0)
- PET-CT and PET-MRI in Neurology – Psychiatric Disorders (2016) (0)
- Chapter 4. Episodic Memory in Mild Cognitive Impairment Inversely Correlates with the Modularity Index of the Cerebral Blood Flow Network (2018) (0)
- P5748Impact of specific crossing techniques in chronic total occlusion percutaneous coronary intervention on recovery of absolute myocardial perfusion (2019) (0)
- 3 MYOCardiaL OxYGen extraCtiOn fraCtiOn Measured usinG bOLus inhaLatiOn Of 15 O-OxYGen Gas and dYnaMiC pOsitrOn eMissiOn tOMOGraphY (2012) (0)
- Mitigation of noise-induced bias of PET radiomic features (2022) (0)
- Impact of wavelet based denoising of [C11](R)-PK11195 time activity curves on accuracy and precision of kinetic analysis. (2008) (0)
- Acknowledgement to Reviewers (2015) (0)
- PARAMETRIC IMAGING OF TAU LOAD IN ALZHEIMER’S PATIENTS AND CONTROLS USING FLORTAUCIPIR (2017) (0)
- Positron emission tomography to assess hypoxia and perfusion in lung cancer World Journal of Clinical Oncology (2014) (0)
- Chapter 2 . 2 Altered GABAA receptor density and unaltered blood-brain barrier [ 11 C ] fl umazenil transport in drug-resistant epilepsy patients with mesial temporal sclerosis (2016) (0)
- [I059] Working in radiotherapy from the perspective of a nuclear medicine physicist (2018) (0)
- Quantification of hypoxia in non-small cell lung cancer patients using [18F]HX4 (2014) (0)
- Amyloid and tau PET relate to memory loss in cognitively normal individuals: the SCIENCe project (2019) (0)
- Validation and test–retest repeatability performance of parametric methods for [11C]UCB-J PET (2022) (0)
- in drug-resistant epilepsy patients with mesial temporal sclerosis (2015) (0)
- Featured Article Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's disease (2016) (0)
- Effects of reusing baseline volumes of interest by non-rigid image registration on PET/CT response classifications (2013) (0)
- Evaluation of [C-11]R116301 as a tracer for the in vivo measurement of NK1 receptors in human subjects (2005) (0)
- Imaging tumor biology with Zr-89-cetuximab, O-15-H2O and F-18-FDG PET/CT in patients with advanced colorectal cancer treated with cetuximab monotherapy (2017) (0)
- Accuracy and quality of parametric CBF, OEF and CMRO2 images: Effects of fixing parameters (2005) (0)
- University of Groningen Optimization of the k(2)' Parameter Estimation for the Pharmacokinetic Modeling of Dynamic PIB PET Scans Using SRTM2 Peretti, (2019) (0)
- University of Groningen F-18-FDG-PET uptake in non-infected total hip prostheses Gelderman (2018) (0)
- [18F]FLORTAUCIPIR BINDING STRONGLY CORRELATES TO COGNITION ACROSS THE CLINICAL ALZHEIMER’S DISEASE CONTINUUM, INDEPENDENTLY OF CSF TAU (2019) (0)
- SAT0100 Increased Vascular Wall Inflammation in Patients with Early Rheumatoid Arthritis as Measured by 18F-FDG-PET/CT (2015) (0)
- Corrigendum to 'Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial' [Eur J Canc 124 (January 2020) 25-36]. (2020) (0)
- 1631PPROGNOSTIC VALUE OF TOTAL LESION GLYCOLYSIS AND METABOLIC TUMOR VOLUME IN NON-SMALL CELL LUNG CANCER. (2014) (0)
- Structural and molecular changes along the continuum of Alzheimer's disease (2011) (0)
- Assessment of microglia activation in schizophrenia using [11C](R)-PK11195 and PET (2005) (0)
- Evaluation of compartment models and semi-quantitative measures for analysing [18F]FDDNP studies (2007) (0)
- Multiparametric evaluation of tumour hypoxia and perfusion using[15O]H2O and [18F]FAZA PET in NSCLC patients (2015) (0)
- University of Groningen [Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer (2019) (0)
- PATH-48. THE DNA METHYLATION LANDSCAPE OF CORE AND PERIPHERAL DIFFUSE GLIOMA REGIONS SHOWS LITTLE SPATIAL SUBTYPE HETEROGENEITY AFTER CONSIDERING TUMOR PURITY (2019) (0)
- Beyond SUV: from false-positive to true positive tumor uptake measures of 89Zr-labeled CD20 monoclonal antibody (2019) (0)
- EP-1895 Multicenter CT phantoms public dataset for radiomics reproducibility studies (2019) (0)
- Comparison of scanner validation phantoms in oncology FDG PET/CT trials (2011) (0)
- 18FDG uptake in esophageal cancer: linking biology and outcome (2006) (0)
- Interobserver variability of image derived input functions for noninvasive pharmacokinetic analysis of PET studies (2014) (0)
- Additional file 1: of An automatic delineation method for bone marrow absorbed dose estimation in 89Zr PET/CT studies (2016) (0)
- Multi-centre Zr-89 cross calibration of PET/CT scanners: assessment of image quality and quantitative accuracy (2012) (0)
- BrainPET Poster Session: Kinetic Modeling (2009) (0)
- Evaluation of the accuracy of the average Mu-values within patients from MR derived Mu-maps (2015) (0)
- Noise and bias characteristics of standardized uptake value (SUV) derived with point spread function (PSF) image reconstruction: should PSF be used for PET tumor uptake quantification ? (2017) (0)
- External Validation Shows That Baseline PET Radiomics Outperform the IPI Risk Score for Prediction of Outcome in DLBCL (2022) (0)
- Can SUVpeak derived from PSF 18F-PET/CT images act as a surrogate for SUVmax derived from EARL compliant reconstructions? (2018) (0)
- Potential of PET to predict cognitive decline along the continuum of Alzheimer's disease (2011) (0)
- Test-retest variability of metabolic tumor volume and SUV: Experimental assessment including repositioning effects (2011) (0)
- TEST-RETEST REPEATABILITY OF [18F]FLORTAUCIPIR PET IN ALZHEIMER’S DISEASE AND CONTROLS (2019) (0)
- Exploring the biomarker cascade model: Relating cortical volume loss to [11C]PiB, [18F]FDG and MMSE over time in Alzheimer's disease patients and normal controls (2012) (0)
- delineation techniques for F-18-FDG PET-CT scans during neoadjuvant extremity soft tissue sarcoma treatment in adults (2018) (0)
- Exploring the biomarker cascade model: Relating cortical volume loss to [11C]PIB, [18F]FDG and MMSE over time in Alzheimer's disease patients and normal controls (2012) (0)
- University of Groningen Optimization of parathyroid C-11-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism Noltes, (2019) (0)
- 18 F-FDG or 3 9-Deoxy-3 9-18 F-Fluorothymidine to Detect Transformation of Follicular Lymphoma (2015) (0)
- Methodological considerations in full kinetic analysis of [18F]FLT PET in patients with non-small cell lung cancer (2013) (0)
- Improved dose regimen for whole-body FDG-PET imaging (2012) (0)
- REVIEWARTICLE Quantification , improvement , and harmonization of small lesion detection with state-ofthe-art PET (2017) (0)
- [11C]phenytoin quantification using parametric methods (2017) (0)
- Pharmacokinetic modelling of P-glycoprotein function at the blood-brain barrier with [F-18]MC225 PET in non-human primates (2019) (0)
- T1211 Early Response Assessment of Neoadjuvant Therapy With Positron Emission Tomography in Patients With Oesophageal Cancer (2010) (0)
- QUANTIFICATION OF TAU LOAD USING [18F]AV-1451 AND PET (2016) (0)
- Performance comparison of Ingenuity TF PET/MRI and Gemini TF PET/CTscanners (2014) (0)
- 4056 Comparison of velocity and acceleration selective arterial spin labeling with 15 O H 2 O positron emission tomography (2013) (0)
- A scale space theory based motion correction approach for dynamic PET brain imaging studies (2022) (0)
- ORIGINAL RESEARCH Open Access Reproducibility of quantitative (R)-( 11 C)verapamil (2012) (0)
- Generating parametric binding potential and volume of distribution images using a novel 2D basis function method and the two tissue compartment plasma input model (2005) (0)
- Quantification of [18F]fluorocholine in prostate cancer (2014) (0)
- University of Groningen Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative F-18-FDG PET / CT analysis (2018) (0)
- Performance Improvements in HYPR-OSEM (2017) (0)
- P.4.032 Neuroinflammation in temporal cortex in schizophrenia patients (2013) (0)
- Longitudinal change in ATN biomarkers in cognitively normal individuals (2022) (0)
- Non-invasive Standardised Uptake Value for Verification of the Use of Previously Validated Reference Region for [18F]Flortaucipir and [18F]Florbetapir Brain PET Studies (2021) (0)
- Manual Versus Artificial Intelligence-Based Segmentations as a Pre-processing Step in Whole-body PET Dosimetry Calculations (2022) (0)
- Image-derived input function for brain imaging using the high-resolution research tomograph (2010) (0)
- Chapter 6 [ 11 C ] phenytoin quantification using parametric methods (2017) (0)
- P1-300: Imaging Alzheimer pathology in vivo: Quantitative comparison of [11C]PIB and [18F]FDDNP (2008) (0)
- Optimization of 11C-choline positron emission tomography protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism (2018) (0)
- PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases (2019) (0)
- BRIEF ARTICLE First Evaluation of ( 11 C)R116301 as an In Vivo Tracer of NK1 Receptors in Man (2009) (0)
- University of Groningen PET segmentation of bulky tumors (2020) (0)
- IC-03-01: Imaging Alzheimer pathology in vivo: Quantitative comparison of [11C]PIB and [18F]FDDNP (2008) (0)
- Quantification of the effects of intravenous contrast on standard uptake value in 18F-FDG PET-CT using a test-retest approach (2010) (0)
- Optimisation of scan duration and image quality in oncological 89Zr immunoPET imaging using the Biograph Vision PET/CT. (2023) (0)
- PET/CT Reconstruction and Its Impact on Quantitative Image Analysis (2015) (0)
- EPISODIC MEMORY IN MILD COGNITIVE IMPAIRMENT INVERSELY CORRELATES WITH THE PATIENT CONTRIBUTION TO CEREBRAL BLOOD FLOW NETWORK MODULARITY (2017) (0)
- Pemetrexed induced thymidylate synthase inhibition in non-small cell lung cancer (NSCLC) in vivo: A pilot study with [18F]FLT PET and clinical outcome (2012) (0)
- Performance evaluation of various reference tissue input parametric methods: For [18F]FDDNP (2007) (0)
- Comparison of bone marrow residence time estimation approaches in 89Zr-PET (2013) (0)
- 18F-FLUORODEOXYGLUCOSE UPTAKE IN NON-INFECTED TOTAL HIP PROSTHESES (2017) (0)
- Prognostic value of quantitative FDG PET/CT uptake metrics in non-small cell lung cancer (2015) (0)
- THE ASSOCIATION BETWEEN [18F]AV1451 PET AND COGNITIVE PERFORMANCE ACROSS THE ALZHEIMER’S DISEASE SPECTRUM (2018) (0)
- [18F]FLORBETAPIR-SPECIFIC BINDING IN RELATION TO COGNITION IN SUBJECTIVE COGNITIVE DECLINE (2018) (0)
- Convolutional neural networks for automatic image quality control and EARL compliance of PET images (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Ronald Boellaard?
Ronald Boellaard is affiliated with the following schools:
